Nadler L M, Ritz J, Bates M P, Park E K, Anderson K C, Sallan S E, Schlossman S F
J Clin Invest. 1982 Aug;70(2):433-42. doi: 10.1172/jci110633.
Leukemic cells from 70% of patients with Ia+CALLA+ non-T cell acute lymphoblastic leukemia (ALL) express an antigen (B1) found on all normal B lymphocytes. In this study, ALL cells that do not express the B1 antigen were studied in an attempt to further elucidate the cellular lineage of these tumors. Non-T cell ALL lines and tumor cells isolated from patients with non-T cell ALL that are Ia + CALLA + B1- were studied in vitro with a variety of agents known to promote cellular differentiation. Phorbol diester (TPA) or phytohemagglutinin conditioned leukocyte culture media were capable of inducing the expression of B1 on all four non-T cell ALL lines tested. In contrast, B1 could not be induced under the identical conditions on a promyelocytic leukemia line or a T cell lymphoblastic leukemia line. With the induction of B1 on non-T cell ALL lines, cytoplasmic mu-heavy chain (c mu) became undetectable, whereas the expression of CALLA and Ia were unchanged. The expression of B1 was accompanied by a decrease of cellular proliferation and DNA synthesis, but not significant morphologic changes were noted. In addition, no other B or T cell antigens were detected. The cellular origin of non-T cell ALL was further investigated using tumor cells isolated from leukemic patients. Tumor cells from eight patients with Ia + CALLA + B1-c mu- ALL could be induced in vitro with TPA to express both B1 and c mu. In contrast, cells from five patients with Ia + CALLA-B1-c mu- non-T cell ALL could not be induced with TPA to express CALLA, B1 or c mu. These studies suggest that the non-T cell ALL are heterogeneous and represent a spectrum of early B cell differentiation including the pre- pre-B cell (Ia + CALLA + B1-c mu-), the intermediate pre-B cell (Ia + CALLA +B1 + c mu-), and finally the "true" pre-B cell (Ia + CALLA + B1 + c mu+). The cellular origin of the remaining Ia + CALLA-B1-c mu- form of non-T cell ALL (20%) is still unknown.
70%的Ia+CALLA+非T细胞急性淋巴细胞白血病(ALL)患者的白血病细胞表达一种在所有正常B淋巴细胞上都能找到的抗原(B1)。在本研究中,对不表达B1抗原的ALL细胞进行了研究,以进一步阐明这些肿瘤的细胞谱系。对从Ia + CALLA + B1-的非T细胞ALL患者中分离出的非T细胞ALL系和肿瘤细胞,在体外使用多种已知能促进细胞分化的试剂进行研究。佛波酯(TPA)或植物血凝素预处理的白细胞培养基能够在所有检测的四个非T细胞ALL系中诱导B1的表达。相比之下,在相同条件下,早幼粒细胞白血病系或T细胞淋巴细胞白血病系无法诱导出B1。随着非T细胞ALL系中B1的诱导,细胞质μ重链(cμ)变得无法检测到,而CALLA和Ia的表达没有变化。B1的表达伴随着细胞增殖和DNA合成的减少,但未观察到明显的形态学变化。此外,未检测到其他B或T细胞抗原。使用从白血病患者分离出的肿瘤细胞进一步研究了非T细胞ALL的细胞起源。来自8例Ia + CALLA + B1-cμ- ALL患者的肿瘤细胞在体外可用TPA诱导表达B1和cμ。相比之下,来自5例Ia + CALLA-B1-cμ-非T细胞ALL患者的细胞用TPA无法诱导表达CALLA、B1或cμ。这些研究表明,非T细胞ALL是异质性的,代表了早期B细胞分化的一个谱系,包括前前B细胞(Ia + CALLA + B1-cμ-)、中间前B细胞(Ia + CALLA +B1 + cμ-),以及最终的“真正”前B细胞(Ia + CALLA + B1 + cμ+)。其余20%的Ia + CALLA-B1-cμ-形式的非T细胞ALL的细胞起源仍然未知。